Joel Greenblatt Adaptive Biotechnologies Corp Transaction History
Gotham Asset Management, LLC
- $21.9 Billion
- Q3 2025
A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Gotham Asset Management, LLC holds 127,064 shares of ADPT stock, worth $1.79 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
127,064
Previous 71,887
76.76%
Holding current value
$1.79 Million
Previous $837,000
127.0%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding ADPT
# of Institutions
290Shares Held
147MCall Options Held
23.5KPut Options Held
33.3K-
Viking Global Investors LP30MShares$423 Million1.27% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$164 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$159 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN5.97MShares$84.2 Million0.02% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.3.65MShares$51.5 Million0.03% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $2.01B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...